Date/Time: August 26th, 4:00 pm – 5:00 pm PDT
Register here: http://uclahs.fyi/biodesign-2021
Event Description: Join UCLA Biodesign for a guest lecture by Paul Upham, Head of Smart Devices at Roche / Genentech, for a discussion on the development of a digital health product at the forefront of technology and breakthrough science. During this talk, you will hear how Roche successfully developed and launched a regulated SaMD product in less than six months as well as the lifecycle of a regulated SaMD product from a regulatory, privacy and security perspective.
Speaker Bio:
Paul Upham is the Head of Smart Devices at Roche / Genentech. Paul has 20+ years of experience in medical device R&D, strategic marketing, product management, clinical research, and medical informatics. Prior to Roche / Genentech, Paul was with Becton Dickinson(BD), as Worldwide Director of Strategic Marketing in their Pharmaceutical Systems business. Paul and his team were responsible for all upstream and downstream marketing strategy for BD’s self-injection business, including pen injectors, autoinjectors, and wearable patch injectors. Prior to that role, Paul was with WellDoc, Inc. as Director of Product Marketing, where he built and led the marketing team and was responsible for product management activities for WellDoc’s portfolio of mobile health solutions. He was also the Core Team Leader for WellDoc’s landmark BlueStar™ product, a class II medical device and the world’s first reimbursed, prescription-only software for type 2 diabetes. Paul’s prior experience includes 10 years at BD in the Diabetes Care business. Paul was responsible for the development and launch of the award-winning BD InterActiv® Diabetes Software, and was a member of the joint BD / Medtronic core team that launched ParadigmLink®, the world’s first wireless blood glucose meter. Paul holds four issued patents in medical software and drug delivery devices and multiple patent applications covering software and medical devices. He is also an author and co-author of numerous peer-reviewed articles in medical informatics and in diabetes. His education background includes undergraduate studies in cognitive science and graduate work in health informatics and finance at the University of Minnesota and New York University.